|
_______________________________________________________________
Dangerous & Addictive Drug OxyContin
Claims
Recently, the Food and Drug
Administration (FDA) informed healthcare professionals of
several claims brought against Purdue Frederick in
connection with several illegal schemes to promote, market
and sell OxyContin. OxyContin is a powerful
prescription pain reliever that the company produces and
sells. The manufacturer's sales force was trained to make
false claims about the product to healthcare professionals,
thereby, misbranding OxyContin by illegally promoting the
drug as being less addictive, less subject to abuse, and
less likely to cause tolerance and withdrawal than other
pain medications. These practices falsely promote the
product and may cause health risks for consumers.
If you or someone you know has suffered
addiction, injuries, or death from an overdose of OxyContin,
please feel free to e-mail Texas
Dangerous Drug Lawyer Jason
Coomer for a free review of your OxyContin claim or use our online
form for a free case evaluation.
All too often big drug companies and
others in the pharmaceutical industry begin to value money
and profits over the health of the consumer. When this
happens these pharmaceutical companies can deceptively
market drugs or hide known dangers of dangerous drugs.
In the case of OxyContin, the drug producer used deceptive
information to push their drugs and made hundreds of
millions of dollars. However, a recent investigation
have uncovered the
extensive, long-term scheme by The Purdue Frederick Company,
Inc. to generate the maximum amount of revenues possible
from the sale of the pain killer, OxyContin. Purdue had a
practice of training its sales representatives to make false
representations to health care providers about the
difficulty of extracting oxycodone, the active ingredient,
from the OxyContin tablet; trained its sales force to
represent to health care providers that OxyContin did not
cause euphoria and was less addictive than immediate-release
opiates; and allowed health care providers to entertain the
erroneous belief that OxyContin was less addictive than
morphine. In addition, Purdue falsely labeled OxyContin as
providing "fewer peaks and valleys than with
immediate-release oxycodone," and falsely represented that
patients taking lower dosages of the drug can always be
discontinued abruptly without suffering withdrawal symptoms
or tolerance.
"FDA will not tolerate practices that
falsely promote drug products and place consumers at health
risk," said Margaret O.K. Glavin, Associate Commissioner for
Regulatory Affairs. "We will continue to do all we can to
protect the public against drug companies and their
representatives who are not truthful and bilk consumers of
precious health care dollars."
To resolve the criminal charges, Purdue
pled guilty to a felony count of misbranding a drug with
intent to defraud and mislead. As part of the plea, Purdue
will pay a $600 million settlement. That amount includes a
criminal fine, restitution to government agencies, over $276
million in forfeiture, and a related civil settlement under
which Purdue will pay $100.6 million to the United States.
If you have lost a person that you love
from an addiction to OxyContin or have suffered severe
damages from addiction or withdraw from the drug,
please feel free to e-mail Texas Dangerous Drug Lawyer Jason
Coomer with your name & contact
information or use our online
form for a free case evaluation.
Texas Dangerous Drug Attorney Jason
Coomer commonly works with other lawyers throughout Texas
including Houston OxyContin Lawyers, San Antonio
Pharmaceutical Lawyers, Dallas Defective Medication Lawyers,
and other Austin Dangerous Drug Claim Lawyers. By
sharing information and working together, his law firm and
other firms throughout Texas are able to provide better
representation for there clients.
|
